Zoledronic acid, a drug currently approved for osteoporosis treatment, has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as a supplemental therapy in ...

SAN ANTONIO (AP) - One of the most promising new approaches for fighting breast cancer took a stunning setback Thursday when a major study showed that a bone-building drug did not stop cancer from ...

A Montana jury yesterday awarded $3.2 million to a woman who sued the makers of the bone-strengthening drug Zometa. The verdict could set a precedent for hundreds of similar cases pending against the ...